Trade GlaxoSmithKline plc - GSK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024151% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001929% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 34.32 |
| Open | 32.96 |
| 1-Year Change | -4.16% |
| Day's Range | 32.77 - 33.43 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | 33.29 | 0.15 | 0.45% | 33.14 | 33.44 | 32.76 |
| Nov 14, 2024 | 34.32 | -0.98 | -2.78% | 35.30 | 35.38 | 34.31 |
| Nov 13, 2024 | 35.06 | -0.11 | -0.31% | 35.17 | 35.23 | 34.76 |
| Nov 12, 2024 | 35.47 | 0.10 | 0.28% | 35.37 | 35.57 | 35.19 |
| Nov 11, 2024 | 36.31 | -0.24 | -0.66% | 36.55 | 36.67 | 36.25 |
| Nov 8, 2024 | 36.24 | 0.16 | 0.44% | 36.08 | 36.36 | 36.02 |
| Nov 7, 2024 | 36.61 | 0.42 | 1.16% | 36.19 | 36.67 | 36.07 |
| Nov 6, 2024 | 35.84 | 0.02 | 0.06% | 35.82 | 36.08 | 35.56 |
| Nov 5, 2024 | 36.95 | 0.32 | 0.87% | 36.63 | 36.99 | 36.43 |
| Nov 4, 2024 | 36.92 | -0.03 | -0.08% | 36.95 | 37.20 | 36.89 |
| Nov 1, 2024 | 36.82 | -0.69 | -1.84% | 37.51 | 37.54 | 36.76 |
| Oct 31, 2024 | 36.68 | 0.46 | 1.27% | 36.22 | 36.89 | 36.01 |
| Oct 30, 2024 | 36.94 | 0.50 | 1.37% | 36.44 | 37.18 | 36.22 |
| Oct 29, 2024 | 38.12 | 0.23 | 0.61% | 37.89 | 38.20 | 37.83 |
| Oct 28, 2024 | 37.84 | 0.26 | 0.69% | 37.58 | 38.02 | 37.58 |
| Oct 25, 2024 | 37.46 | -0.41 | -1.08% | 37.87 | 37.95 | 37.38 |
| Oct 24, 2024 | 37.69 | -0.31 | -0.82% | 38.00 | 38.13 | 37.61 |
| Oct 23, 2024 | 37.88 | 0.17 | 0.45% | 37.71 | 37.93 | 37.60 |
| Oct 22, 2024 | 37.92 | 0.26 | 0.69% | 37.66 | 37.99 | 37.64 |
| Oct 21, 2024 | 38.11 | -0.30 | -0.78% | 38.41 | 38.45 | 38.03 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
GlaxoSmithKline Company profile
About GlaxoSmithKline plc (ADR)
GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, GlaxoSmithKline plc (ADR) revenues increased less than 1% to £34.11B. Net income decreased 24% to £4.39B. Revenues reflect Pharmaceuticals segment increase of 4% to £17.73B, US segment increase of 4% to £15.09B, also reflect Consumer Healthcare segment decrease of 4% to £9.61B, Vaccines segment decrease of 3% to £6.78B, Unallocated segment decrease from £28M to £0K.
Equity composition
Ordinary Shs. 25p Par, 05/11, 10B auth., 5,657,488,184 issd., less 494,074,284 Treas. shs. @ Cost. Insiders own 0.02%. PO: NA. 11/91, 9/89, & 2/86,2-for-1 stock splits. 2/00, Company formed through merger with SmithKline Beecham plc @ 1 ADR-for-1.138 ADS of GSK and Glaxo Wellcome plc @ 1.
| Industry: | Pharmaceuticals (NEC) |
980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com